Interleukin-13 is an endothelial chemotaxin

Pathobiology

Volumn 65, Issue 6, 1996, Pages 287-292

  Halloran, Margaret M ^a   Haskell, Catherine J ^a   Woods, James M ^a   Hosaka, Shigeru ^a   Koch, Alisa E ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Chemotaxis; Cytokine; Endothelial cells; Interleukin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOTAXIN; CYTOKINE; INTERLEUKIN 13; LYMPHOKINE;

ARTICLE; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0031474147     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164140     Document Type: Article

References (24)

1. Minty A, Chalon P, Dcrocq JM, Dumont X, Guillemot JC., Kaghad M., Labit C, Leplatois P, Liauzun P., Miloux B., Minty C, Casellas P., Loi-son G, Lupker J, Shire D, Ferrara P., Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory’ and immune responses., Nature 1993:362:248-250.
2. McKenzie ANJ, Culpepper JA, deWaal Male-fyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W., Cocks BG., Mcnon S., de Vries JE., Banchereau J., Zurawski G: Interleukin 13., a T-cell derived cytokine that regulates human monocyte and B-cell function., Proc Natl Acad Sci USA 1993;90:3735-3739.
3. D’Andrea A., Ma X, Aste-Amczaga M., Paganin C., Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor u production., J Exp Med 1995;181:537-546.
4. Mart PH., Ahem MJ., Smith MD., Finlay-Jones JJ: Regulatory effects of 1L-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis., Clin Exp Immunol 1995;99:331-337.
5. Yano S., Sone S., Nishioka Y, Mukaida N, Matsushima K., Ogura T: Differential effects of anti-inflammatory cytokines (IL-4., II.-10., and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor., J Leuk Biol 1995;57:303-309.
6. Vita N, Lefort S., Laurent P, Caput D, Ferrara P: Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types., J Biol Chem 1995;270:3512-3517.
7. Zurawski SM., Vega F Jr., Huyghe B, Zurawski G: Receptors for interleukin-13 and interleu-kin-4 are complex and share a novel component that functions in signal transduction., EM BO J 1993;12:2663-2670.
8. Zurawski G., de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells., Immunol Today 1994;15:19-26.
9. Nilsson G., Nilsson K: Effects of interleukin ILF 13 on immediate-early response gene expression., phenotype and differentiation of human mast cells: Comparison with IL-4., Eur J Immunol 1995;25:870-873.
10. Nassar GM., Morrows JD., Roberts II LJ., Lak-kis FG., Badr KF: Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes., J Biol Chem 1994;269:27631-27634.
11. Marfaing-Koka A, Devergne O., Gorgone G., Pootier A, Schall TJ, Galanaud Pemilie D: Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-y plus TNF-a and inhibition by IL-4 and IL-13., J Immunol 1995; 154:1870- 1878.
12. Koch AE., Halloran MM., Haskell CJ., Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule expression., Nature 1995; 376:517-519.
13. Renard N, Duvert V., Banchereau J., Saeland S: Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors., Blood 1994;84:2253-2260.
14. Magazin M, Guillemont JC., Vita N, Ferrara P: Interleukin-13 is a monocyte chemoattractant., Eur Cytokine Netw 1994:5:397-400.
15. Lind M, Deleuran B., Yssel H, Fink-Erikson E., Thestrup-Pederson K: IL-4 and IL-13, but not IL-10., are chemotactic factors for human osteoblasts., Cytokine 1995;7:78-82.
16. Vannier E, deWaal Malcfyt R., Salazar-Montes A, de Vries JE, Dinarello CA: Interleukin-13 (IL-13) induces receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: Inhibition by an IL-4 mutant protein., Blood 1996:87:3307-3315.
17. Girad D., Paquin R, Naccachc PH., Beaulieu AD: Effects of interleukin-13 on human neutrophil functions., J Leuk Biol 1996:59:412-419.
18. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP: IL-13 selectively induces vascular adhesion molecule-1 expression in human endothelial cells., J Immunol 1995: 154:799-803.
19. DeWaal Malcfyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J., Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes; Comparison with IL-4 and modulation by INF-y or IL-10., J Immunol 1993;151:6370-6381.
20. Elices MJ., Osborn L., Takada Y., Crouse C., Luhowskyj S, Hemler ME., Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site., Cell 1990: 60:577-584.
21. Szekanccz Z, Szegedi G, Koch AE: Cellular adhesion molecules in rheumatoid arthritis: Regulation by cytokines and possible clinical importance., J Investig Med 1996:44:124-135.
22. Folkman J, Shing Y: Angiogenesis., J Biol Chem 1992;267:10931-10934.
23. Fajardo LF., Kwan HH., Kowalski J., Prionas SD., Allison AC: Dual role of tumor necrosis factor-u in angiogenesis., Am J Pathol 1992; 140:539-544.
24. Hockel M, Sasse J, Wissler JH: Purified mono-cyte-cerivcd angiogenic substance (angiotro-pin) stimulates migration, phenotypic changes, and ‘lube formation’ but not proliferation of capillary endothelial cells in vitro., J Cell Physiol 1987;133:1-13.